1623 Capital’s Teladoc Health TDOC Stock Holding History

1623 Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$333K	–	79
2021 Q2	$333K	Buy	+2,000	New	+$324K	0.13%	66

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

1623 Capital's TDOC Position: Q2 2022 in Review

1623 Capital sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 10,051 shares — an estimated $725K sold.

1623 Capital first reported a position in TDOC in Q1 2021 and held it in 4 quarters. The position peaked at $725K in Q1 2022. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

1623 Capital reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
1623 Capital sold 10,051 Teladoc Health shares in Q2 2022, an estimated $725K.
1623 Capital first reported a position in Teladoc Health in Q1 2021 and held it in 4 quarters.
1623 Capital's Teladoc Health position peaked at $725K in Q1 2022.
551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on 1623 Capital's 13F filing for Q2 2022, filed 12 Aug 2022.